Stock splits & bonuses
Corporate actions that change the share count without changing the company: stock splits and bonus issues of one-for-one or larger, approved by the board, record-dated or allotted inside the window. The filing on each row gives the ratio and, once fixed, the record date.
| Company | Why it’s here — the filing | vs market · Next day / 1w / 1m | Price | Mcap |
|---|---|---|---|---|
| Rs 2 interim dividend and proposed 2-for-1 bonus issue | pending — —raw -6.1 — —vs Nifty Microcap 250 | ₹985 | 5,675 Cr | |
| Rs 1 interim dividend as Q2 profit rises 43% | pending — —raw +0.6 — —vs Nifty Microcap 250 | ₹572 | 11,856 Cr | |
| Board approves five-way share split to Rs 1 face value | -12.4% — —raw -11.6 — —vs Nifty Microcap 250 | ₹3,148 | 5,335 Cr | |
| Concord Biotech approves 1:1 bonus issue and doubles authorised capital | -5.7% -9.4% -5.5%raw -7.0 -12.2 -15.5vs Nifty Smallcap 250 | ₹628 | 6,570 Cr | |
| Goodluck India allots bonus shares in 2:1 ratio | -6.6% -2.0% +7.8%raw -6.8 -2.8 +8.1vs Nifty Microcap 250 | ₹542 | 5,400 Cr |
A company appears when an NSE/BSE filing inside the last 90 days carries one of these classifier signals (minimum importance: Medium): Stock split, Bonus issue of 1:1 or better. Each row shows the latest qualifying filing; the reaction columns are the stock’s measured move from the close before that filing to the close of the next day (one session after the reaction day), 1 week and 1 month later. vs market subtracts the move of the company’s size index (Nifty 100, Nifty Midcap 150, Nifty Smallcap 250, or Nifty Microcap 250 for smaller and SME companies) over the same two closes; for filings before June 2026 that is the index membership as recorded later (tracked since Jun 2026). vs sector subtracts the median move of its industry peers. Both are differences in percentage points, not a measure of what the filing did. A benchmark that has not landed yet reads “pending”: the index close arrives a session after the stock’s.
MarketPing publishes facts, filings and measured history only — nothing on this page is investment advice, a recommendation or a rating.